embolization: Clinical Trials

4 trials of embolization, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow embolization: new trials by email Literature Review of embolization trials Research Report on embolization

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Everolimus, embolization, Doxorubicin - Neuroendocrine Tumors, Hepatic Metastases
Phase 2CompletedFederation Francophone de Cancerologie Digestive742012-12-012024-09-25
Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas
embolization - Leiomyomas, Fertility
Phase 2CompletedAssistance Publique - Hôpitaux de Paris162009-02-012019-06-20
Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF
GM-CSF, Embolization - Uveal Melanoma, Liver Metastases
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University532004-10-012025-05-16
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
cisplatin, doxorubicin, mitomycin - Liver Cancer, Metastatic Cancer
Phase 2CompletedEastern Cooperative Oncology Group501999-12-152023-07-05

Conditions studied

Neoplasm Metastasis (2)  ·  Carcinoma, Hepatocellular (1)  ·  Leiomyoma (1)  ·  Liver Neoplasms (1)  ·  Neoplasms (1)  ·  Neuroendocrine Tumors (1)  ·  Uveal Melanoma (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Federation Francophone de Cancerologie Digestive (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

France (2)  ·  United States (2)

Top investigators

Keith E. Stuart, MD (1)  ·  Takami Sato, M.D., Ph.D. (1)

Results publications

PMID 31678771

NIH funding

R21CA103250 (1), U10CA021115 (1)